- Home
- CLX vs ILMN Comparison
CLX vs ILMN Comparison
Compare CLX & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLX
- ILMN
- Stock Information
- Founded
- CLX 1913
- ILMN 1998
- Country
- CLX United States
- ILMN United States
- Employees
- CLX N/A
- ILMN N/A
- Industry
- CLX Specialty Chemicals
- ILMN Medical Specialities
- Sector
- CLX Consumer Discretionary
- ILMN Health Care
- Exchange
- CLX Nasdaq
- ILMN Nasdaq
- Market Cap
- CLX 15.1B
- ILMN 13.1B
- IPO Year
- CLX N/A
- ILMN 2000
- Fundamental
- Price
- CLX $124.02
- ILMN $97.15
- Analyst Decision
- CLX Hold
- ILMN Buy
- Analyst Count
- CLX 12
- ILMN 17
- Target Price
- CLX $148.00
- ILMN $124.35
- AVG Volume (30 Days)
- CLX 2.0M
- ILMN 2.4M
- Earning Date
- CLX 07-31-2025
- ILMN 07-31-2025
- Dividend Yield
- CLX 3.93%
- ILMN N/A
- EPS Growth
- CLX 188.97
- ILMN N/A
- EPS
- CLX 5.57
- ILMN N/A
- Revenue
- CLX $7,019,000,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- CLX $0.42
- ILMN N/A
- Revenue Next Year
- CLX N/A
- ILMN $3.15
- P/E Ratio
- CLX $22.29
- ILMN N/A
- Revenue Growth
- CLX N/A
- ILMN N/A
- 52 Week Low
- CLX $117.35
- ILMN $68.70
- 52 Week High
- CLX $171.37
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- CLX 45.43
- ILMN 59.14
- Support Level
- CLX $123.53
- ILMN $95.09
- Resistance Level
- CLX $128.79
- ILMN $101.28
- Average True Range (ATR)
- CLX 2.31
- ILMN 3.31
- MACD
- CLX 0.83
- ILMN -0.27
- Stochastic Oscillator
- CLX 58.30
- ILMN 58.10
About CLX Clorox Company (The)
Since its start more than 100 years ago, Clorox has expanded to operate in a variety of consumer products categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.